JP2019524884A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524884A5
JP2019524884A5 JP2019529463A JP2019529463A JP2019524884A5 JP 2019524884 A5 JP2019524884 A5 JP 2019524884A5 JP 2019529463 A JP2019529463 A JP 2019529463A JP 2019529463 A JP2019529463 A JP 2019529463A JP 2019524884 A5 JP2019524884 A5 JP 2019524884A5
Authority
JP
Japan
Prior art keywords
pla2r
cells
seq
epitope
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019529463A
Other languages
English (en)
Japanese (ja)
Other versions
JP7303107B2 (ja
JP2019524884A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/046626 external-priority patent/WO2018031947A1/en
Publication of JP2019524884A publication Critical patent/JP2019524884A/ja
Publication of JP2019524884A5 publication Critical patent/JP2019524884A5/ja
Priority to JP2022076451A priority Critical patent/JP7411718B2/ja
Application granted granted Critical
Publication of JP7303107B2 publication Critical patent/JP7303107B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019529463A 2016-08-12 2017-08-11 自己免疫疾患の診断、予防、および／または治療 Active JP7303107B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022076451A JP7411718B2 (ja) 2016-08-12 2022-05-06 自己免疫疾患の診断、予防、および／または治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662374382P 2016-08-12 2016-08-12
US62/374,382 2016-08-12
PCT/US2017/046626 WO2018031947A1 (en) 2016-08-12 2017-08-11 Diagnosis, prevention, and/or treatment of autoimmune diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022076451A Division JP7411718B2 (ja) 2016-08-12 2022-05-06 自己免疫疾患の診断、予防、および／または治療

Publications (3)

Publication Number Publication Date
JP2019524884A JP2019524884A (ja) 2019-09-05
JP2019524884A5 true JP2019524884A5 (https=) 2020-09-03
JP7303107B2 JP7303107B2 (ja) 2023-07-04

Family

ID=61163324

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529463A Active JP7303107B2 (ja) 2016-08-12 2017-08-11 自己免疫疾患の診断、予防、および／または治療
JP2022076451A Active JP7411718B2 (ja) 2016-08-12 2022-05-06 自己免疫疾患の診断、予防、および／または治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022076451A Active JP7411718B2 (ja) 2016-08-12 2022-05-06 自己免疫疾患の診断、予防、および／または治療

Country Status (6)

Country Link
US (3) US11266717B2 (https=)
EP (2) EP3497452B1 (https=)
JP (2) JP7303107B2 (https=)
CN (1) CN109891245B (https=)
ES (1) ES3014985T3 (https=)
WO (1) WO2018031947A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109891245B (zh) * 2016-08-12 2023-05-05 美国创新免疫科技有限公司 自身免疫疾病的诊断、预防和/或治疗
CN112312930A (zh) * 2018-05-02 2021-02-02 宾夕法尼亚大学董事会 磷脂酶a2受体嵌合自身抗体受体t细胞的组合物和方法
WO2020037135A1 (en) 2018-08-15 2020-02-20 Charlesworth M Cristine Methods and materials for identifying and treating membranous nephropathy
EP4010704A1 (en) 2019-08-06 2022-06-15 Euroimmun Medizinische Labordiagnostika AG An improved autoantibody detection assay
EP4031676A4 (en) 2019-09-19 2023-10-25 Mayo Foundation for Medical Education and Research Methods and materials for identifying and treating membranous nephropathy
EP4117702A4 (en) * 2020-03-06 2024-03-13 Mayo Foundation for Medical Education and Research Methods and materials for identifying and treating membranous nephropathy
CN112111015B (zh) * 2020-09-24 2021-12-07 苏州携创生物技术有限公司 PLA2R、C1q、THSD7A融合蛋白及其构建方法、应用
CN112557670A (zh) * 2020-12-07 2021-03-26 东南大学 一种基于尿液外泌体pla2r检测imn的方法、试剂盒及其应用
BR102021022687A2 (pt) 2020-12-11 2022-06-28 Euroimmun Medizinische Labordiagnostika Ag Método e reagentes para diagnosticar nefropatia membranosa
EP4380963A4 (en) * 2021-08-05 2025-06-04 The Trustees of The University of Pennsylvania Compositions and methods of chimeric autoantibody receptor cells expressing extended phospholipase a2 receptor fragments
CN114588881B (zh) * 2022-03-07 2023-07-18 大连理工大学 免疫吸附剂及其制备方法
WO2023183474A1 (en) * 2022-03-23 2023-09-28 Bodhi Bio Llc Antigen-specific therapy for autoimmune diseases
CN116082517B (zh) * 2022-05-26 2025-08-22 成都地奥制药集团有限公司 融合蛋白及其用途
WO2024147113A1 (en) * 2023-01-05 2024-07-11 Glycoera Ag Glycoengineered polypeptides targeting anti-podocyte autoantibodies and uses thereof
CN115951047A (zh) * 2023-02-10 2023-04-11 大连大学 自身免疫性水疱病PBMCs直接免疫荧光诊断试剂盒
EP4709746A1 (en) * 2023-05-08 2026-03-18 Canopy Immuno-Therapeutics Ltd. Ig-like fusion proteins for treating membranous nephropathy
US20250382348A1 (en) * 2024-06-13 2025-12-18 Astero BioPharma LLC Approaches for the selective depletion of pla2r-specific antibodies

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051989T3 (es) 1988-10-21 1994-07-01 Akzo Nv Un procedimiento para la manufactura de una inmunotoxina para el tratamiento o profilaxis de una enfermedad autoinmune.
JPH07278196A (ja) * 1994-04-05 1995-10-24 Shionogi & Co Ltd ヒトｉ型ホスホリパーゼａ２レセプター
JP2004505029A (ja) 2000-08-01 2004-02-19 ザ・ユニバーシティ・オブ・カンザス 細胞内に取り込まれるペプチド−薬剤複合体
ES2618543T3 (es) * 2005-11-23 2017-06-21 Genentech, Inc. Métodos y composiciones relacionados con ensayos de linfocitos B
EP2145684A3 (en) * 2008-07-14 2013-06-26 Samsung Electronics Co., Ltd. Microfluidic device, sample analyzing method using the same, and dilution ration measuring method
DK2313778T3 (en) * 2008-07-18 2015-04-27 Boston Medical Ct Corp Diagnostics for membranous nephropathy
WO2012145112A2 (en) 2011-04-18 2012-10-26 Immunogen, Inc. Novel maytansinoid derivatives with sulfoxide linker
FI3467509T3 (fi) * 2011-05-04 2026-02-11 Cellular Tech Ltd Cns-antigeenispesifisiä b-solu-, t-solu- ja vasta-ainemäärityksiä ja niiden käyttötapoja multippeliskleroosin diagnosoinnissa ja hoidossa
CN107236735B (zh) 2012-06-21 2019-11-08 米拉根医疗股份有限公司 包含锁核酸基序的基于寡核苷酸的抑制剂
EP3027652A1 (en) * 2013-07-09 2016-06-08 Institut National de la Santé et de la Recherche Médicale (INSERM) Anti-pla2r antibody and uses thereof
GB201410108D0 (en) * 2014-06-06 2014-07-23 Univ Manchester Peptides, and methods and apparatus utilising same
CN104849452A (zh) * 2015-05-14 2015-08-19 深圳市伯劳特生物制品有限公司 一种pla2r抗体定量检测试纸条及制作、检测方法
CN105510575A (zh) * 2015-12-04 2016-04-20 深圳市伯劳特生物制品有限公司 抗磷脂酶A2受体抗体IgG试剂盒及检测方法
CN109891245B (zh) * 2016-08-12 2023-05-05 美国创新免疫科技有限公司 自身免疫疾病的诊断、预防和/或治疗

Similar Documents

Publication Publication Date Title
JP2019524884A5 (https=)
Mohankumar et al. Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer
AU2017313138B2 (en) A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
JP2014239695A5 (https=)
JP2014144959A5 (https=)
JP2017108751A5 (https=)
JP2016507233A5 (https=)
JP2017503488A5 (https=)
JP2014516549A (ja) ヘッジホッグ阻害剤療法のためのバイオマーカー
US10895572B2 (en) Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients
JP2014516543A5 (https=)
JP2015523569A5 (https=)
AU2025238057A1 (en) Methods for prostate cancer detection and treatment
RU2013113314A (ru) Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками
JP2015504299A5 (https=)
ES2721539T3 (es) Materiales y métodos para pronóstico de evolución de esófago de Barrett
KR20160134817A (ko) 암 치료
JP2013536442A5 (https=)
Liu et al. Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study
CN107541563A (zh) 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用
JP2018527886A5 (https=)
Wang et al. Establishment of a quantitative polymerase chain reaction assay for monitoring chimeric antigen receptor T cells in peripheral blood
JP2017516501A (ja) 肺がんのタイピング法
CN109022584B (zh) 一种食管癌的分子标志物及其用途
RU2013104137A (ru) Изоформы bard1 при раке легкого и колоректальном раке и их применение